Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder

被引：196
|
作者：
Cortese, Samuele [1 ,2 ,3 ]
机构：
[1] Univ Southampton, Ctr Innovat Mental Hlth, Sch Psychol,Fac Environm & Life Sci, Clin & Expt Sci CNS & Psychiat,Fac Med, Southampton, Hants, England
[2] Univ Nottingham, Sch Med, Inst Mental Hlth, Div Psychiat & Appl Psychol, Nottingham, England
[3] NYU, Grossman Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 11期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; STIMULANT-MEDICATION; ADHD; CHILDREN; DISCONTINUATION; METAANALYSIS;
D O I：
10.1056/NEJMra1917069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Amphetamines and methylphenidate and, less often, nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD. Inattentiveness and restlessness are improved more than quality-of-life measures in short-term trials.
引用
收藏
页码：1050 / 1056
页数：7
相关论文
共 50 条
  • [21] Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case series
    Oncu, Bedriye
    Er, Okan
    Colak, Burcin
    Nutt, David J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (03) : 282 - 283
  • [22] Familiality of neural preparation and response control in childhood attention deficit-hyperactivity disorder
    Albrecht, B.
    Brandeis, D.
    Uebel, H.
    Valko, L.
    Heinrich, H.
    Drechsler, R.
    Heise, A.
    Mueller, U. C.
    Steinhausen, H. -C.
    Rothenberger, A.
    Banaschewski, T.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (09) : 1997 - 2011
  • [23] Attention deficit-hyperactivity disorder, comorbidities, and risk situations
    Reinhardt, Marcelo C.
    Reinhardt, Caciane A. U.
    JORNAL DE PEDIATRIA, 2013, 89 (02) : 124 - 130
  • [24] Treatment of Attention-Deficit/Hyperactivity Disorder
    Pierce, Karen
    PEDIATRIC ANNALS, 2011, 40 (11): : 556 - 562
  • [25] Treatment Approaches to Attention Deficit Hyperactivity Disorder
    Antai-Otong, Deborah
    Zimmerman, Michele L.
    NURSING CLINICS OF NORTH AMERICA, 2016, 51 (02) : 199 - +
  • [26] Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
    Edinoff, Amber N.
    Akuly, Haseeb A.
    Wagner, John H.
    Boudreaux, Megan A.
    Kaplan, Leah A.
    Yusuf, Shadman
    Neuchat, Elisa E.
    Cornett, Elyse M.
    Boyer, Andrea G.
    Kaye, Adam M.
    Kaye, Alan D.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [27] Treatment of Attention-Deficit Hyperactivity Disorder
    Kim, Young Key
    Song, Dong Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (05): : 489 - 499
  • [28] Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome
    Herguner, Sabri
    Harmanci, Hatice
    Toy, Harun
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2015, 50 (03): : 317 - 325
  • [29] Statistical Evidence Suggests that Inattention Drives Hyperactivity/Impulsivity in Attention Deficit-Hyperactivity Disorder
    Sokolova, Elena
    Groot, Perry
    Claassen, Tom
    van Hulzen, Kimm J.
    Glennon, Jeffrey C.
    Franke, Barbara
    Heskes, Tom
    Buitelaar, Jan
    PLOS ONE, 2016, 11 (10):
  • [30] Attention Deficit Hyperactivity Disorder in Athletes
    Ciocca, Mario
    CLINICS IN SPORTS MEDICINE, 2019, 38 (04) : 545 - +
12345